Published in Oncotarget on December 26, 2016
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene (2003) 3.53
Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology (2009) 2.93
Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res (2006) 2.60
Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res (2008) 2.45
NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem (2009) 2.03
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol (2000) 1.82
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther (2007) 1.80
Ist1 regulates Vps4 localization and assembly. Mol Biol Cell (2007) 1.68
Novel Ist1-Did2 complex functions at a late step in multivesicular body sorting. Mol Biol Cell (2007) 1.63
Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res (2005) 1.22
Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood (2002) 1.07
Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. J Surg Oncol (2011) 1.01
The ubiquitin-proteasome pathway and enhanced activity of NF-kappaB in gastric carcinoma. J Surg Oncol (2008) 0.95
Overexpression of OLC1, cigarette smoke, and human lung tumorigenesis. J Natl Cancer Inst (2008) 0.93
Cigarette smoke suppresses the ubiquitin-dependent degradation of OLC1. Biochem Biophys Res Commun (2011) 0.84
Over-expression of the overexpressed in lung cancer 1 is associated with poor prognosis in epithelial ovarian cancer. J Surg Oncol (2013) 0.78
Over-expression of the overexpressed in lung cancer-1 is associated with poor prognosis in colorectal cancer. Anticancer Res (2014) 0.78
Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma. PLoS One (2014) 0.78
OLC1 is overexpressed in breast cancer and its expression correlates with poor patient survival. Tumour Biol (2014) 0.78